Tung, Chun-Liang <br/><br/>
Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells.  [electronic resource] 

 -  Experimental cell research  08 2017 
 - 59-66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1090-2422 
<br/><br/><label>Standard No.: </label>10.1016/j.yexcr.2017.04.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>ErbB Receptors--metabolism<br/>Erlotinib Hydrochloride--pharmacology<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pyrans--pharmacology<br/>Thymidylate Synthase--metabolism